Metconazole

CAS : 125116-23-6

Ref. 3D-FM46463

Informations sur le produit

• Nom: Metconazole
• Synonymes: 5-[(4-Chlorophenyl)methyl]-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol(1RS,5RS,1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimeth yl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1Rs,5Rs, 1RS,5RS)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, 5-((4-chlorophenyl)methyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, 5-(4-Chlorophenylmethyl)-2,2-Dimethyl-1-(1H-1,2,4-Triazol-1-Ylmethyl)Cyclopentanol, 5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, Caramba, Cyclopentanol, 5-(4-chlorophenyl)methyl-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)-, Dimetconazole, Metaconazole, Metconazole (Bsi,Pa Iso), Metlock, Metlock, 5-[(4-chlorophenyl)methyl]-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)-, Quash, Sunorg Pro, Tourney, Work-up Flowable
• CAS: 125116-23-6

Description

Metconazole is a triazole antifungal drug with systemic activity. It inhibits the synthesis of ergosterol and other sterols, which are essential for fungal cell membranes. Metconazole has been shown to have synergistic effects when combined with other fungicides in a lc-ms/ms method for analysis of terminal residues in wheat. The most frequent adverse effect of metconazole treatment is photosensitivity. Metconazole has been studied extensively for its potential carcinogenic properties, but there is no conclusive evidence that it causes cancer in humans or animals. There have been conflicting results from studies on the carcinogenic potential of metconazole.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 319.83 g/mol
• Formule: C₁₇H₂₂ClN₃O
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C17H22ClN3O/c1-16(2)8-7-14(9-13-3-5-15(18)6-4-13)17(16,22)10-21-12-19-11-20-21/h3-6,11-12,14,22H,7-10H2,1-2H3
• Code InChI: InChIKey=XWPZUHJBOLQNMN-UHFFFAOYSA-N
• SMILES: CC1(C)CCC(Cc2ccc(Cl)cc2)C1(O)Cn1cncn1